The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells

Angiogenesis

Volumn 15, Issue 4, 2012, Pages 697-711

  Song, Nan ^a   Ding, Yanping ^a   Zhuo, Wei ^a   He, Ting ^a   Fu, Zhiguang ^a   Chen, Yang ^a   Song, Xiaomin ^a   Fu, Yan ^a   Luo, Yongzhang ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Endostatin; Integrin 5 1; Nuclear translocation; Nucleolin

Indexed keywords

CLATHRIN; ENDOSTATIN; KARYOPHERIN; KARYOPHERIN ALPHA1BETA1; NUCLEOLIN; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL CELL; ARTICLE; CAVEOLA; CELL NUCLEUS; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RNA INTERFERENCE; TRANSPORT KINETICS;

EID: 84875054866     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9284-y     Document Type: Article

References (56)

1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182-1186.
2. Abdollahi A, Hlatky L, Huber PE (2005) Endostatin: the logic of antiangiogenic therapy. Drug Resist Updat 8(1-2):59-74. (Pubitemid 40797957)
3. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79(2):315-328. (Pubitemid 24324921)
4. OReilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2):277-285. (Pubitemid 28015876)
5. Maeshima Y, Colorado PC, Kalluri R (2000) Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 275(31):23745-23750. (Pubitemid 30624661)
6. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R (2000) Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275(2):1209-1215. (Pubitemid 30051173)
7. Nyberg P, Xie L, Sugimoto H, Colorado P, Sund M, Holthaus K, Sudhakar A, Salo T, Kalluri R (2008) Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrindependent collagen-derived tumor suppressor. Exp Cell Res 314(18):3292-3305.
8. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87(17):6624-6628.
9. Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF, Bouck N (1995) Inhibition of angiogenesis by thrombospondin- 2. Biochem Biophys Res Commun 217(1):326-332.
10. Kohn EC (1998) Endostatin and angiostatin: the next anti-angiogenesis generation. Angiogenesis 2(1):25-27. (Pubitemid 128511969)
11. Sim BK (1998) Angiostatin and endostatin: endothelial cellspecific endogenous inhibitors of angiogenesis and tumor growth. Angiogenesis 2(1):37-48. (Pubitemid 128511971)
12. Folkman J (2007) Endostatin finds a new partner: nucleolin. Blood 110(8):2786-2787. (Pubitemid 350006924)
13. Faye C, Moreau C, Chautard E, Jetne R, Fukai N, Ruggiero F, Humphries MJ, Olsen BR, Ricard-Blum S (2009) Molecular interplay between endostatin, integrins, and heparan sulfate. J Biol Chem 284(33):22029-22040.
14. Shi HB, Huang YJ, Zhou H, Song XM, Yuan SP, Fu Y, Luo YZ (2007) Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 110(8):2899-2906. (Pubitemid 350006943)
15. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci USA 100(8):4766-4771. (Pubitemid 36457804)
16. Wickstrom SA, Alitalo K, Keski-Oja J (2002) Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res 62(19):5580-5589.
17. Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z, Keiser N, Kalluri R, Zeng H, Mukhopadhyay D, Chen RL, Lander AD, Hagihara K, Yamaguchi Y, Sasisekharan R, Cantley L, Sukhatme VP (2001) Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 7(4):811-822. (Pubitemid 32436441)
18. Huang Y, Shi H, Zhou H, Song X, Yuan S, Luo Y (2006) The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 107(9): 3564-3571.
19. Javaherian K, Park SY, Pickl WF, LaMontagne KR, Sjin RT, Gillies S, Lo KM (2002) Laminin modulates morphogenic properties of the collagen XVIII endostatin domain. J Biol Chem 277(47):45211-45218. (Pubitemid 36159125)
20. MacDonald NJ, Shivers WY, Narum DL, Plum SM, Wingard JN, Fuhrmann SR, Liang H, Holland-Linn J, Chen DH, Sim BK (2001) Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin. J Biol Chem 276(27): 25190-25196.
21. Lee SJ, Jang JW, Kim YM, Lee HI, Jeon JY, Kwon YG, Lee ST (2002) Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett 519(1-3):147-152. (Pubitemid 34522008)
22. Wickstrom SA, Veikkola T, Rehn M, Pihlajaniemi T, Alitalo K, Keski-Oja J (2001) Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res 61(17):6511-6516. (Pubitemid 32783258)
23. Wickstrom SA, Alitalo K, Keski-Oja J (2005) Endostatin signaling and regulation of endothelial cell-matrix interactions. Adv Cancer Res 94:197-229. (Pubitemid 41202366)
24. Wickstrom SA, Alitalo K, Keski-Oja J (2003) Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J Biol Chem 278(39):37895-37901. (Pubitemid 37175319)
25. Chen Y, Wang S, Lu X, Zhang H, Fu Y, Luo Y (2011) Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. Blood 117(23):6392-6403.
26. Song N, Huang Y, Shi H, Yuan S, Ding Y, Song X, Fu Y, Luo Y (2009) Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor- 1alpha/CXCR4 axis. Cancer Res 69(15):6057-6064.
27. Stepanova V, Lebedeva T, Kuo A, Yarovoi S, Tkachuk S, Zaitsev S, Bdeir K, Dumler I, Marks MS, Parfyonova Y, Tkachuk VA, Higazi AA, Cines DB (2008) Nuclear translocation of urokinasetype plasminogen activator. Blood 112(1):100-110.
28. Lamaze C, Fujimoto LM, Yin HL, Schmid SL (1997) The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. J Biol Chem 272(33):20332-20335. (Pubitemid 27355580)
29. McMahon HT, Boucrot E (2011) Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 12(8):517-533.
30. Legrand D, Vigie K, Said EA, Elass E, Masson M, Slomianny MC, Carpentier M, Briand JP, Mazurier J, Hovanessian AG (2004) Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 271(2):303-317. (Pubitemid 38130458)
31. Ginisty H, Sicard H, Roger B, Bouvet P (1999) Structure and functions of nucleolin. J Cell Sci 112(6):761-772. (Pubitemid 29179310)
32. Barel M, Meibom K, Charbit A (2010) Nucleolin, a shuttle protein promoting infection of human monocytes by Francisella tularensis. PLoS One 5(12):e14193.
33. Goretzki L, Mueller BM (1997) Receptor-mediated endocytosis of urokinase-type plasminogen activator is regulated by cAMPdependent protein kinase. J Cell Sci 110(Pt 12):1395-1402. (Pubitemid 27299935)
34. Czekay RP, Kuemmel TA, Orlando RA, Farquhar MG (2001) Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Mol Biol Cell 12(5): 1467-1479. (Pubitemid 33044425)
35. Wei Y, Czekay RP, Robillard L, Kugler MC, Zhang F, Kim KK, Xiong JP, Humphries MJ, Chapman HA (2005) Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding. J Cell Biol 168(3):501-511. (Pubitemid 40205071)
36. Shin S, Wolgamott L, Yoon SO (2012) Integrin trafficking and tumor progression. Int J Cell Biol 2012:516789.
37. Goldfarb DS, Corbett AH, Mason DA, Harreman MT, Adam SA (2004) Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol 14(9):505-514. (Pubitemid 39209358)
38. Mosammaparast N, Pemberton LF (2004) Karyopherins: from nuclear-transport mediators to nuclear-function regulators. Trends Cell Biol 14(10):547-556. (Pubitemid 39296617)
39. Schmidt-Zachmann MS, Nigg EA (1993) Protein localization to the nucleolus: a search for targeting domains in nucleolin. J Cell Sci 105(Pt 3):799-806. (Pubitemid 23243212)
40. Fu Y, Tang H, Huang Y, Song N, Luo Y (2009) Unraveling the mysteries of endostatin. IUBMB Life 61(6):613-626.
41. Fu Y, Luo Y (2010) The N-terminal integrity is critical for the stability and biological functions of endostatin. Biochemistry 49(30):6420-6429.
42. Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B, Ramchandran R, Pestell R, Sukhatme VP (2002) Endostatin causes G(1) arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem 277(19):16464-16469. (Pubitemid 34967659)
43. Kim YM, Hwang S, Pyun BJ, Kim TY, Lee ST, Gho YS, Kwon YG (2002) Endostatin blocks vascular endothelial growth factormediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 277(31):27872-27879. (Pubitemid 34966733)
44. Yu Y, Moulton KS, Khan MK, Vineberg S, Boye E, Davis VM, O'Donnell PE, Bischoff J, Milstone DS (2004) E-selectin is required for the antiangiogenic activity of endostatin. Proc Natl Acad Sci USA 101(21):8005-8010. (Pubitemid 38698044)
45. Han Q, Fu Y, Zhou H, He Y, Luo Y (2007) Contributions of Zn(II)-binding to the structural stability of endostatin. FEBS Lett 581(16):3027-3032. (Pubitemid 46908809)
46. Ding YH, Javaherian K, Lo KM, Chopra R, Boehm T, Lanciotti J, Harris BA, Li Y, Shapiro R, Hohenester E, Timpl R, Folkman J, Wiley DC (1998) Zinc-dependent dimers observed in crystals of human endostatin. Proc Natl Acad Sci USA 95(18):10443-10448. (Pubitemid 28413086)
47. Tjin Tham Sjin RM, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K (2005) A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity. Cancer Res 65(9):3656-3663 . (Pubitemid 40616342)
48. Nyborg JK, Peersen OB (2004) That zincing feeling: the effects of EDTA on the behaviour of zinc-binding transcriptional regulators. Biochem J 381(Pt 3):e3-e4.
49. Fogal V, Sugahara KN, Ruoslahti E, Christian S (2009) Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis 12(1):91-100.
50. Krust B, El Khoury D, Nondier I, Soundaramourty C, Hovanessian AG (2011) Targeting surface nucleolin with multivalent HB- 19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type. BMC Cancer 11:333.
51. Dumler I, Stepanova V, Jerke U, Mayboroda OA, Vogel F, Bouvet P, Tkachuk V, Haller H, Gulba DC (1999) Urokinaseinduced mitogenesis is mediated by casein kinase 2 and nucleolin. Curr Biol 9(24):1468-1476. (Pubitemid 30023481)
52. Kusakawa T, Shimakami T, Kaneko S, Yoshioka K, Murakami S (2007) Functional interaction of hepatitis C Virus NS5B with Nucleolin GAR domain. J Biochem 141(6):917-927. (Pubitemid 351455332)
53. Kibbey MC, Johnson B, Petryshyn R, Jucker M, Kleinman HK (1995) A 110-kD nuclear shuttling protein, nucleolin, binds to the neurite-promoting IKVAV site of laminin-1. J Neurosci Res 42(3):314-322.
54. Ginisty H, Amalric F, Bouvet P (1998) Nucleolin functions in the first step of ribosomal RNA processing. EMBO J 17(5): 1476-1486. (Pubitemid 28105526)
55. Shibata Y, Muramatsu T, Hirai M, Inui T, Kimura T, Saito H, McCormick LM, Bu G, Kadomatsu K (2002) Nuclear targeting by the growth factor midkine. Mol Cell Biol 22(19):6788-6796.
56. Rehn M, Veikkola T, Kukk-Valdre E, Nakamura H, Ilmonen M, Lombardo C, Pihlajaniemi T, Alitalo K, Vuori K (2001) Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 98(3):1024-1029. (Pubitemid 32121180)